Lars Jorgensen
Lars Jorgensen is the CEO of Novo Nordisk, a leading global healthcare company based in Denmark, known for its innovative diabetes and obesity treatments. Under his leadership, the company announced a significant investment of R$ 6.4 billion to expand its manufacturing facility in Montes Claros, Brazil, highlighting the strategic importance of the Brazilian market for Novo Nordisk.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| Slovakia | 1 | 5.00 | 0.05% | +0% | 5,459,642 | 2,860 | $110,000 | 58$ |
| Brazil | 1 | 8.00 | 0.06% | +0% | 211,049,527 | 116,666 | $1,500,000 | 829$ |
| Liechtenstein | 1 | 9.00 | 0.06% | +0% | 38,137 | 24 | $6,900 | 4$ |
| Totals | 3 | 216,547,306 | 119,550 | $1,616,900 | 891$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Liechtenstein:
Lars Jorgensen is the CEO of Novo Nordisk and announced a significant investment in Brazil.
9